0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Clinical Challenge | 
Moeko Hotta, MD; Mitsuhito Ota, MD, PhD
JAMA. 2016;315(3):295-296. doi:10.1001/jama.2015.13673.

News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2016;315(3):243. doi:10.1001/jama.2015.18375.

Health Agencies Update | 
Bridget M. Kuehn
JAMA. 2008;299(24):2847. doi:10.1001/jama.299.24.2847-b.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Dermatology
Research Letter  | 
Dirty Dots as a Normal Trichoscopic Finding in the Elderly Scalp
Mariya Miteva, MD; Mariana Lima, MD; Antonella Tosti, MD
JAMA Dermatology
Original Investigation  | 
Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome
Timothy H. Schmidt, MD, PhD; Keshav Khanijow, MD; Marcelle I. Cedars, MD; et al.
JAMA Dermatology
Observation  | 
Topical Ruxolitinib for the Treatment of Alopecia Universalis
Brittany G. Craiglow, MD; Daniel Tavares, PharmD; Brett A. King, MD, PhD
JAMA Dermatology
Observation  | 
Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
Arjun Dhayalan, BS; Brett A. King, MD, PhD